Assessing the quality of cancer screening leaflets using the International Patient Decision Aids Standards instrument: A cross-sectional content analysis.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 33846033.
- Also identified by DOI 10.1016/j.pec.2021.03.034.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To assess the quality of national cancer screening program leaflets in Japan from the informed-decision perspective. Cross-sectional content analysis of invitation leaflets issued by centralized organizations and used nationwide in Japan was conducted. Three members independently evaluated the materials using International Patient Decision Aids Standards six-item minimum criteria for qualifying patient decision aids. Co-author KH is a cancer patient himself. We also sought feedbacks from three other cancer survivors and two bereaved family members. Inter-rater agreement was substantial (Fleiss' kappa=0.62). The median score was 2 out of 6 (range: 2-3). All leaflets described the cancer (Q1: 7/7) and screening modality (Q2: 7/7). None stated not undergoing screening as an option. One stated another screening modality (Q3: 1/7). None stated both the positive and negative features of multiple options (Q4: 0/7. Q5: 0/7). One described the psychological and social experience of screening but only its positive side (Q6: 1/7). There is room for improvement in the content of the public cancer screening invitation leaflets in Japan from informed-decision perspective. Cancer screening leaflets should provide evidence-based, well-balanced, easy-to-understand information to educate people on cancer screening while maintaining people's autonomy.
Medical subject headings
- Early Detection of Cancer
- Neoplasms